6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f] isoquinoline compound useful in the treatment of cancer
PK144920APending Publication Date: 2026-11-05ASTRAZENECA AB
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201700519
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2017-10-06
- Publication Date
- 2026-11-05
Abstract
The specification relates to compound of Formula (I): to process and for their preparation, to pharmaceutical composition containing them and the treatment of cell proliferative disorders.
Need to check novelty before this filing date? Find Prior Art
